CLINICAL_TRIALS
trial_result
· 2018-10-10
Clinical Trial Update: A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies [Phase 1]
Summary
Phase 1 trial update of a single ProHema CB product for pediatric hematologic malignancies; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fate Therapeutics | Conditions: Hematologic Malignancies | Phase 1 | Status: TERMINATED | Results posted: 2018-10-10